|
1-20 (of 2168) related articles
Items per page
| |
|
Enzon's Abuchowski Bounces Back
Enzon Pharmaceuticals cofounder Abe Abuchowski has been relatively low profile since he quit the Bridgewater-based company 12 years ... (PERIODICAL ARTICLE)
Food and Drug Administration: Approval and Oversight of the Drug Mifeprex.
GAO-08-751 August 7, 2008 In September 2000, the Food and Drug Administration (FDA), part of the Department of ... (PERIODICAL ARTICLE)
Post-marketing studies common
A TUFTS Center for the Study of Drug Development analysis said post-approval study commitments are becoming the norm, ... (PERIODICAL ARTICLE)
Breaking down metabolomics.
The metabolome is the full set of metabolites--the chemical fingerprints left behind by cellular processes--in an organism. The ... (PERIODICAL ARTICLE)
FDA panel finds Chiron's cyclosporine inhalation
solution safe, but evenly...
Chiron Corporation, Emeryville, CA, announced that a majority of the US Food and Drug Administration's (FDA) Pulmonary-Allergy Drugs ... (PERIODICAL ARTICLE)
Odyssey Thera granted United States Patent for animalimaging.
Odyssey Thera, Inc. (San Ramon, CA) announced that the United States Patent and Trademark Office granted United States ... (PERIODICAL ARTICLE)
Should drug efficacy law be repealed?
If some of the FDAs critics had their way, it would be "back to the future" for the ... (PERIODICAL ARTICLE)
Von Eschenbach's vision
Imagine (we all have bad dreams from time to time) that you've been appointed FDA Commissioner. You know, ... (PERIODICAL ARTICLE)
WASHINGTON INSIDER: Update
The FDA's director of orphan products development for the past 19 years, Marlene Haffner, will retire in January ... (PERIODICAL ARTICLE)
Pharmaceuticals.
A new report, "Pharma 2020: The Vision" from PWC finds that drug companies will change how they do ... (PERIODICAL ARTICLE)
Potential Interactions of the Orphan Drug Act and Pharmacogenomics: A Flood...
I. INTRODUCTION To overcome the unattractiveness of small markets, the United States government provides financial aid and incentives ... (PERIODICAL ARTICLE)
Amgen recovering nicely from anemia drug woes.
If you're a patient in need of treatment or services, recent developments in the Valley healthcare scene mean ... (PERIODICAL ARTICLE)
Dietary Supplements: Balancing Consumer Choice & Safety
A Review of the New York State Task Force on Life & the Law's Report Dietary Supplements: Balancing ... (PERIODICAL ARTICLE)
Long live consumer education
It is a fact of life that direct-to-consumer (DTC) promotion has become increasingly educational-as addressed by PhRMA's guidelines ... (PERIODICAL ARTICLE)
Federal Regulation of Genetic Testing Neglect
HEADNOTE Government needs to ensure that genetic tests provide useful medical information and that the test results are ... (PERIODICAL ARTICLE)
CuraGen develops of predictive drug development
assay.
CuraGen Corporation (New Haven CT), a genomics-based pharmaceutical company, announced the development of a new cell-based assay system ... (PERIODICAL ARTICLE)
Pearls before swine? Potential trade-offs between the
human and animal use...
Antibiotics have dramatically improved our capacity to treat infectious diseases of bacterial origin. Indicative of their importance in ... (PERIODICAL ARTICLE)
You need therapy.
TherapyEdge Inc. has announced the release of TherapyEdge HIV, a Web-delivered decision-support system. The system graphically tracks and ... (PERIODICAL ARTICLE)
What's behind uptick in journal ads?
Medical journal advertising enjoyed some notable gains in the third quarter of this year. Was it the result ... (PERIODICAL ARTICLE)
Economics of the Pharmaceutical Industry.
The pharmaceutical industry is important because it is a major source of medical innovation. The U.S. research-based industry ... (PERIODICAL ARTICLE) | |
|
1-20 (of 2168) related articles
Items per page
1-20 (of 2168) related articles
|